Novobind Revenue and Competitors
Estimated Revenue & Valuation
- Novobind's estimated annual revenue is currently $2.3M per year.
- Novobind's estimated revenue per employee is $155,000
Employee Data
- Novobind has 15 Employees.
- Novobind grew their employee count by -6% last year.
Novobind's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
3 | Scientist | Reveal Email/Phone |
Novobind Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.8M | 49 | 20% | $40M | N/A |
#2 | $0.2M | 2 | 0% | N/A | N/A |
#3 | $1.6M | 21 | -12% | N/A | N/A |
#4 | $3.4M | 22 | 29% | N/A | N/A |
#5 | $13.5M | 87 | 5% | N/A | N/A |
#6 | $2M | 26 | 8% | $89.5M | N/A |
#7 | $2.8M | 18 | 0% | N/A | N/A |
#8 | $49.1M | 317 | 21% | N/A | N/A |
#9 | $1.1M | 7 | 0% | N/A | N/A |
#10 | $0.8M | 5 | 25% | N/A | N/A |
What Is Novobind?
NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety. We target pathogens that cause >$1B of production losses and have been materially affected by the following: 1) Antibacterial resistance, 2) A Regulatory ban on antibiotics, and; 3) Changing consumer sentiment.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 15 | -29% | $3M |
#2 | $2M | 15 | 7% | N/A |
#3 | $2.5M | 15 | -25% | N/A |
#4 | $0.8M | 15 | 15% | $13.3M |
#5 | $1.3M | 15 | -17% | N/A |